UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:November 30,
Aprea Therapeutics (NASDAQ:APRE)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Aprea Therapeutics Charts.
Aprea Therapeutics (NASDAQ:APRE)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Aprea Therapeutics Charts.

Aprea Therapeutics, Inc. News

Form 8-K - Current report
Monday 17 June 2024 (1 month ago) • Edgar (US Regulatory)
Form 8-K - Current report
Tuesday 14 May 2024 (2 months ago) • Edgar (US Regulatory)
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Tuesday 14 May 2024 (2 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Tuesday 6 February 2024 (6 months ago) • Edgar (US Regulatory)
Form EFFECT - Notice of Effectiveness
Sunday 4 February 2024 (6 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Friday 2 February 2024 (6 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Friday 26 January 2024 (6 months ago) • Edgar (US Regulatory)
Form S-3 - Registration statement under Securities Act of 1933
Friday 26 January 2024 (6 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Thursday 4 January 2024 (7 months ago) • Edgar (US Regulatory)
Form S-8 - Securities to be offered to employees in employee benefit plans
Thursday 9 November 2023 (8 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Thursday 9 November 2023 (8 months ago) • Edgar (US Regulatory)
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 9 November 2023 (8 months ago) • Edgar (US Regulatory)

More Aprea Therapeutics, Inc. News Articles